Logotype for Karolinska Development

Karolinska Development (KDEV) investor relations material

Karolinska Development Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Karolinska Development
Q3 2025 earnings summary14 Nov, 2025

Executive summary

  • Net loss for Q3 2025 was SEK -66.8 million, a significant decline from SEK -10.9 million in Q3 2024; nine-month net loss reached SEK -154.3 million compared to SEK -26.7 million year-over-year.

  • Portfolio fair value decreased to SEK 1,346.7 million at September 2025, down SEK 38.2 million from the previous quarter, mainly due to revaluation of Umecrine Cognition and a decline in Modus Therapeutics' share price.

  • Investments in portfolio companies totaled SEK 28.4 million in Q3 2025, up from SEK 19.8 million in Q3 2024.

Financial highlights

  • Net sales for Q3 2025 were SEK 0.3 million (Q3 2024: SEK 0.4 million); nine-month sales were SEK 1.2 million (2024: SEK 1.3 million).

  • Change in fair value of shares in portfolio companies for Q3 2025 was SEK -65.4 million (Q3 2024: SEK -7.9 million); for the nine months, SEK -80.3 million (2024: SEK -17.1 million).

  • Net asset value at September 2025 was SEK 1,085.4 million (SEK 4.0 per share), down from SEK 1,224.4 million (SEK 4.5 per share) a year earlier.

  • Cash and cash equivalents stood at SEK 44.5 million at quarter-end, up from SEK 29.3 million a year earlier.

  • Earnings per share for Q3 2025 were SEK -0.25 (Q3 2024: SEK -0.04); for the nine months, SEK -0.57 (2024: SEK -0.10).

Outlook and guidance

  • Several portfolio companies are approaching key clinical data readouts in late 2025 and early 2026, which could drive value inflection.

  • Ongoing focus on supporting existing portfolio companies through challenging capital markets, with continued evaluation of exit and licensing opportunities.

Quantify OG-6219 discontinuation's financial impact.
Assess current cash position and runway.
Identify next major portfolio value inflection points.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Karolinska Development earnings date

Logotype for Karolinska Development
Q4 202513 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Karolinska Development earnings date

Logotype for Karolinska Development
Q4 202513 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Karolinska Development AB is a Sweden-based investment company that plays a significant role in the biotechnology sector. It is primarily engaged in providing capital, developing, and commercializing biotechnological products. The company's activities span a broad range of medical and therapeutic areas, including oncology, infections and wound healing, women’s health, cardiovascular and hematology, as well as medical equipment and diagnostics. Karolinska Development AB showcases a diverse portfolio that comprises investments in pharmaceutical research and development, healthcare technology, gene research and development, drug delivery technologies, and life sciences tools, among others. Founded in 2003 and with a modest team, the company focuses on fostering innovation and advancing the development of new treatments and medical solutions. The company is headquartered in Solna, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage